ARCHIVES

NCI Division Directors Seek Litton Phaseout, NIH Takeover At Frederick

This article is from The Cancer Letter archive.

Vol. 04 No. 43 | October 27, 1978

Download PDF Visit The Full Archive

Related Articles

DCT Board Questions Funding, Direction Of IL-2/LAK Trials

March 3, 1989

FDA Declares Taxol Orphan Drug For KS; Can IVAX Break Bristol’s Exclusivity?

August 15, 1997

New England Medical Center Discloses Case Of Two Overdoses

April 28, 1995

Ibrutinib Demonstrates Responses In Large B-Cell Lymphomas

April 27, 2012

Early ADT Doesn’t Offer Survival Advantage—ASCO

April 27, 2007

In Brief: Edwards Takes A Parting Shot At Cancer Program; “Forward Plan” Calls For Emphasis On Prevention

January 17, 1975